Potential role of ustekinumab in the treatment of chronic plaque psoriasis
Santo Raffaele Mercuri1, Luigi Naldi21Unità di Dermatologia, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Università Vita-Salute, Milano, Italy; 2Centro Studi GISED, Fondazione per la Ricerca Ospedale Maggiore, Unità di Dermatologia,...
Guardado en:
Autores principales: | Santo Raffaele Mercuri, Luigi Naldi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c6f57a6657543289370aadc5dfe79ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ustekinumab in the therapy of chronic plaque psoriasis
por: Jenna L O’Neill, et al.
Publicado: (2009) -
Infliximab for the treatment of plaque psoriasis
por: Jennifer S Gall, et al.
Publicado: (2008) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018) -
Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
por: Nicolazzo D, et al.
Publicado: (2014) -
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
por: Hampton P, et al.
Publicado: (2021)